A 3-year-old child from rural Uttar Pradesh presents with corneal scarring and blindness. On examination, the cornea shows a white, opaque scar with loss of normal architecture. Which is the most common stage of xerophthalmia that leads to irreversible blindness if left untreated?

## Most Common Cause of Irreversible Blindness in Xerophthalmia **Key Point:** Corneal scarring (XS stage) is the most common stage of xerophthalmia that results in permanent, irreversible blindness in vitamin A deficiency. ### WHO Classification of Xerophthalmia Stages | Stage | Clinical Finding | Reversibility | Frequency as Cause of Blindness | |-------|------------------|----------------|----------------------------------| | XN | Night blindness | Fully reversible | Not a cause of blindness | | X1A | Conjunctival xerosis | Reversible | Rare | | X1B | Bitot's spots | Reversible | Rare | | X2 | Corneal xerosis | Partially reversible | Uncommon | | XS | Corneal scarring | **Irreversible** | **Most common** | | XF | Corneal melting/perforation | Irreversible | Less common (more acute) | **High-Yield:** XS (corneal scarring) is the single most frequent cause of preventable blindness in children in developing countries, particularly in South Asia and Sub-Saharan Africa. Once scarring occurs, vitamin A supplementation cannot restore vision. ### Pathophysiology of Progression 1. Vitamin A depletion → loss of goblet cells and squamous metaplasia 2. Corneal xerosis develops (loss of transparency) 3. Corneal melting and ulceration occur (enzymatic damage) 4. Scarring and opacification result (permanent structural damage) **Clinical Pearl:** The progression from X2 (corneal xerosis) to XS (scarring) can occur within days to weeks if vitamin A is not repleted. Early recognition and urgent high-dose vitamin A therapy (200,000 IU on days 1, 2, and 14) can prevent progression to scarring. **Warning:** Do not confuse XS with XF. XF (corneal melting/perforation) is more acute and dramatic but less common as a cause of chronic blindness; XS (scarring) is the most frequent endpoint of untreated xerophthalmia.